id	sid	tid	token	lemma	pos
dpc-5766	1	1	dermatology	dermatology	NOUN
dpc-5766	1	2	:	:	PUNCT
dpc-5766	1	3	practical	practical	ADJ
dpc-5766	1	4	and	and	CCONJ
dpc-5766	1	5	conceptual	conceptual	ADJ
dpc-5766	1	6	research	research	NOUN
dpc-5766	1	7	letter	letter	NOUN
dpc-5766	2	1	|	|	ADV
dpc-5766	2	2	dermatol	dermatol	ADJ
dpc-5766	2	3	pract	pract	NOUN
dpc-5766	2	4	concept	concept	NOUN
dpc-5766	2	5	.	.	PUNCT
dpc-5766	3	1	2025;15(4):5766	2025;15(4):5766	NUM
dpc-5766	3	2	1	1	NUM
dpc-5766	3	3	treatment	treatment	NOUN
dpc-5766	3	4	strategies	strategy	NOUN
dpc-5766	3	5	for	for	ADP
dpc-5766	3	6	atopic	atopic	NOUN
dpc-5766	3	7	dermatitis	dermatitis	NOUN
dpc-5766	3	8	in	in	ADP
dpc-5766	3	9	adults	adult	NOUN
dpc-5766	3	10	who	who	PRON
dpc-5766	3	11	exhibit	exhibit	VERB
dpc-5766	3	12	non	non	ADJ
dpc-5766	3	13	-	-	ADJ
dpc-5766	3	14	allergic	allergic	ADJ
dpc-5766	3	15	comorbidities꞉	comorbidities꞉	X
dpc-5766	4	1	real	real	ADJ
dpc-5766	4	2	-	-	PUNCT
dpc-5766	4	3	life	life	NOUN
dpc-5766	4	4	data	datum	NOUN
dpc-5766	4	5	from	from	ADP
dpc-5766	4	6	a	a	DET
dpc-5766	4	7	tertiary	tertiary	ADJ
dpc-5766	4	8	greek	greek	NOUN
dpc-5766	4	9	hospital	hospital	NOUN
dpc-5766	4	10	εleni	εleni	NOUN
dpc-5766	4	11	paschou1	paschou1	NOUN
dpc-5766	4	12	,	,	PUNCT
dpc-5766	4	13	αimilios	αimilio	NOUN
dpc-5766	4	14	lallas1	lallas1	PROPN
dpc-5766	4	15	,	,	PUNCT
dpc-5766	4	16	katerina	katerina	PROPN
dpc-5766	4	17	bakirtzi1	bakirtzi1	PROPN
dpc-5766	4	18	,	,	PUNCT
dpc-5766	4	19	dimitra	dimitra	PROPN
dpc-5766	4	20	kiritsi1,2	kiritsi1,2	PROPN
dpc-5766	4	21	,	,	PUNCT
dpc-5766	4	22	efstratios	efstratio	NOUN
dpc-5766	4	23	vakirlis1	vakirlis1	PROPN
dpc-5766	4	24	,	,	PUNCT
dpc-5766	4	25	eleni	eleni	PROPN
dpc-5766	4	26	sotiriou1	sotiriou1	NOUN
dpc-5766	4	27	1	1	NUM
dpc-5766	4	28	first	first	ADJ
dpc-5766	4	29	department	department	NOUN
dpc-5766	4	30	of	of	ADP
dpc-5766	4	31	dermatology	dermatology	NOUN
dpc-5766	4	32	and	and	CCONJ
dpc-5766	4	33	venereology	venereology	NOUN
dpc-5766	4	34	,	,	PUNCT
dpc-5766	4	35	school	school	NOUN
dpc-5766	4	36	of	of	ADP
dpc-5766	4	37	medicine	medicine	NOUN
dpc-5766	4	38	,	,	PUNCT
dpc-5766	4	39	aristotle	aristotle	PROPN
dpc-5766	4	40	university	university	PROPN
dpc-5766	4	41	of	of	ADP
dpc-5766	4	42	thessaloniki	thessaloniki	PROPN
dpc-5766	4	43	2	2	PROPN
dpc-5766	4	44	department	department	NOUN
dpc-5766	4	45	of	of	ADP
dpc-5766	4	46	dermatology	dermatology	NOUN
dpc-5766	4	47	,	,	PUNCT
dpc-5766	4	48	faculty	faculty	NOUN
dpc-5766	4	49	of	of	ADP
dpc-5766	4	50	medicine	medicine	NOUN
dpc-5766	4	51	,	,	PUNCT
dpc-5766	4	52	medical	medical	ADJ
dpc-5766	4	53	centre	centre	NOUN
dpc-5766	4	54	-	-	PUNCT
dpc-5766	4	55	university	university	NOUN
dpc-5766	4	56	of	of	ADP
dpc-5766	4	57	freiburg	freiburg	PROPN
dpc-5766	4	58	,	,	PUNCT
dpc-5766	4	59	freiburg	freiburg	PROPN
dpc-5766	4	60	,	,	PUNCT
dpc-5766	4	61	germany	germany	PROPN
dpc-5766	4	62	key	key	ADJ
dpc-5766	4	63	words	word	NOUN
dpc-5766	4	64	:	:	PUNCT
dpc-5766	4	65	atopic	atopic	NOUN
dpc-5766	4	66	dermatitis	dermatitis	NOUN
dpc-5766	4	67	,	,	PUNCT
dpc-5766	4	68	comorbidities	comorbiditie	NOUN
dpc-5766	4	69	,	,	PUNCT
dpc-5766	4	70	treatment	treatment	NOUN
dpc-5766	4	71	,	,	PUNCT
dpc-5766	4	72	real	real	ADJ
dpc-5766	4	73	life	life	NOUN
dpc-5766	4	74	citation	citation	NOUN
dpc-5766	4	75	:	:	PUNCT
dpc-5766	4	76	paschou	paschou	NOUN
dpc-5766	4	77	e	e	NOUN
dpc-5766	4	78	,	,	PUNCT
dpc-5766	4	79	lallas	lallas	PROPN
dpc-5766	4	80	a	a	PRON
dpc-5766	4	81	,	,	PUNCT
dpc-5766	4	82	bakirtzi	bakirtzi	VERB
dpc-5766	4	83	k	k	X
dpc-5766	4	84	,	,	PUNCT
dpc-5766	4	85	kiritsi	kiritsi	PROPN
dpc-5766	4	86	d	d	PROPN
dpc-5766	4	87	,	,	PUNCT
dpc-5766	4	88	vakirlis	vakirlis	ADJ
dpc-5766	4	89	e	e	NOUN
dpc-5766	4	90	,	,	PUNCT
dpc-5766	4	91	sotiriou	sotiriou	PROPN
dpc-5766	4	92	e.	e.	PROPN
dpc-5766	4	93	treatment	treatment	NOUN
dpc-5766	4	94	strategies	strategy	NOUN
dpc-5766	4	95	for	for	ADP
dpc-5766	4	96	atopic	atopic	NOUN
dpc-5766	4	97	dermatitis	dermatitis	NOUN
dpc-5766	4	98	in	in	ADP
dpc-5766	4	99	adults	adult	NOUN
dpc-5766	4	100	who	who	PRON
dpc-5766	4	101	exhibit	exhibit	VERB
dpc-5766	4	102	non	non	ADJ
dpc-5766	4	103	-	-	ADJ
dpc-5766	4	104	allergic	allergic	ADJ
dpc-5766	4	105	comorbidities꞉	comorbidities꞉	X
dpc-5766	5	1	real	real	ADJ
dpc-5766	5	2	-	-	PUNCT
dpc-5766	5	3	life	life	NOUN
dpc-5766	5	4	data	datum	NOUN
dpc-5766	5	5	from	from	ADP
dpc-5766	5	6	a	a	DET
dpc-5766	5	7	tertiary	tertiary	ADJ
dpc-5766	5	8	greek	greek	NOUN
dpc-5766	5	9	hospital	hospital	NOUN
dpc-5766	5	10	.	.	PUNCT
dpc-5766	6	1	dermatol	dermatol	NOUN
dpc-5766	6	2	pract	pract	PROPN
dpc-5766	6	3	concept	concept	NOUN
dpc-5766	6	4	.	.	PUNCT
dpc-5766	7	1	2025;15(4):5766	2025;15(4):5766	NUM
dpc-5766	7	2	.	.	PUNCT
dpc-5766	8	1	doi	doi	NOUN
dpc-5766	8	2	:	:	PUNCT
dpc-5766	8	3	https://doi	https://doi	PROPN
dpc-5766	8	4	.	.	PUNCT
dpc-5766	8	5	org/10.5826	org/10.5826	NUM
dpc-5766	8	6	/	/	SYM
dpc-5766	8	7	dpc.1504a5766	dpc.1504a5766	NOUN
dpc-5766	8	8	accepted	accept	VERB
dpc-5766	8	9	:	:	PUNCT
dpc-5766	8	10	sptember	sptember	NOUN
dpc-5766	8	11	8	8	NUM
dpc-5766	8	12	,	,	PUNCT
dpc-5766	8	13	2025	2025	NUM
dpc-5766	8	14	;	;	PUNCT
dpc-5766	8	15	published	publish	VERB
dpc-5766	8	16	:	:	PUNCT
dpc-5766	9	1	october	october	PROPN
dpc-5766	9	2	2025	2025	NUM
dpc-5766	9	3	copyright	copyright	NOUN
dpc-5766	9	4	:	:	PUNCT
dpc-5766	9	5	©	©	PROPN
dpc-5766	9	6	2025	2025	NUM
dpc-5766	9	7	paschou	paschou	NOUN
dpc-5766	9	8	et	et	PROPN
dpc-5766	9	9	al	al	PROPN
dpc-5766	9	10	.	.	PUNCT
dpc-5766	10	1	this	this	PRON
dpc-5766	10	2	is	be	AUX
dpc-5766	10	3	an	an	DET
dpc-5766	10	4	open	open	ADJ
dpc-5766	10	5	-	-	PUNCT
dpc-5766	10	6	access	access	NOUN
dpc-5766	10	7	article	article	NOUN
dpc-5766	10	8	distributed	distribute	VERB
dpc-5766	10	9	under	under	ADP
dpc-5766	10	10	the	the	DET
dpc-5766	10	11	terms	term	NOUN
dpc-5766	10	12	of	of	ADP
dpc-5766	10	13	the	the	DET
dpc-5766	10	14	creative	creative	ADJ
dpc-5766	10	15	commons	common	NOUN
dpc-5766	10	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5766	10	17	license	license	NOUN
dpc-5766	10	18	(	(	PUNCT
dpc-5766	10	19	by	by	ADP
dpc-5766	10	20	-	-	PUNCT
dpc-5766	10	21	nc-4.0	nc-4.0	NOUN
dpc-5766	10	22	)	)	PUNCT
dpc-5766	10	23	,	,	PUNCT
dpc-5766	10	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5766	10	25	,	,	PUNCT
dpc-5766	10	26	which	which	PRON
dpc-5766	10	27	permits	permit	VERB
dpc-5766	10	28	unrestricted	unrestricted	ADJ
dpc-5766	10	29	noncommercial	noncommercial	ADJ
dpc-5766	10	30	use	use	NOUN
dpc-5766	10	31	,	,	PUNCT
dpc-5766	10	32	distribution	distribution	NOUN
dpc-5766	10	33	,	,	PUNCT
dpc-5766	10	34	and	and	CCONJ
dpc-5766	10	35	reproduction	reproduction	NOUN
dpc-5766	10	36	in	in	ADP
dpc-5766	10	37	any	any	DET
dpc-5766	10	38	medium	medium	NOUN
dpc-5766	10	39	,	,	PUNCT
dpc-5766	10	40	provided	provide	VERB
dpc-5766	10	41	the	the	DET
dpc-5766	10	42	original	original	ADJ
dpc-5766	10	43	authors	author	NOUN
dpc-5766	10	44	and	and	CCONJ
dpc-5766	10	45	source	source	NOUN
dpc-5766	10	46	are	be	AUX
dpc-5766	10	47	credited	credit	VERB
dpc-5766	10	48	.	.	PUNCT
dpc-5766	11	1	funding	funding	NOUN
dpc-5766	11	2	:	:	PUNCT
dpc-5766	11	3	none	none	NOUN
dpc-5766	11	4	.	.	PUNCT
dpc-5766	12	1	competing	compete	VERB
dpc-5766	12	2	interests	interest	NOUN
dpc-5766	12	3	:	:	PUNCT
dpc-5766	12	4	none	none	NOUN
dpc-5766	12	5	.	.	PUNCT
dpc-5766	13	1	authorship	authorship	NOUN
dpc-5766	13	2	:	:	PUNCT
dpc-5766	13	3	all	all	DET
dpc-5766	13	4	authors	author	NOUN
dpc-5766	13	5	have	have	AUX
dpc-5766	13	6	contributed	contribute	VERB
dpc-5766	13	7	significantly	significantly	ADV
dpc-5766	13	8	to	to	ADP
dpc-5766	13	9	this	this	DET
dpc-5766	13	10	publication	publication	NOUN
dpc-5766	13	11	.	.	PUNCT
dpc-5766	14	1	corresponding	correspond	VERB
dpc-5766	14	2	author	author	NOUN
dpc-5766	14	3	:	:	PUNCT
dpc-5766	14	4	dr	dr	PROPN
dpc-5766	14	5	paschou	paschou	PROPN
dpc-5766	14	6	eleni	eleni	PROPN
dpc-5766	14	7	,	,	PUNCT
dpc-5766	14	8	first	first	ADJ
dpc-5766	14	9	department	department	NOUN
dpc-5766	14	10	of	of	ADP
dpc-5766	14	11	dermatology	dermatology	NOUN
dpc-5766	14	12	and	and	CCONJ
dpc-5766	14	13	venereology	venereology	NOUN
dpc-5766	14	14	,	,	PUNCT
dpc-5766	14	15	school	school	NOUN
dpc-5766	14	16	of	of	ADP
dpc-5766	14	17	medicine	medicine	NOUN
dpc-5766	14	18	,	,	PUNCT
dpc-5766	14	19	aristotle	aristotle	PROPN
dpc-5766	14	20	university	university	PROPN
dpc-5766	14	21	of	of	ADP
dpc-5766	14	22	thessaloniki	thessaloniki	PROPN
dpc-5766	14	23	,	,	PUNCT
dpc-5766	14	24	124	124	NUM
dpc-5766	14	25	delfon	delfon	NOUN
dpc-5766	14	26	,	,	PUNCT
dpc-5766	14	27	54643	54643	NUM
dpc-5766	14	28	,	,	PUNCT
dpc-5766	14	29	thessaloniki	thessaloniki	PROPN
dpc-5766	14	30	,	,	PUNCT
dpc-5766	14	31	greece	greece	PROPN
dpc-5766	14	32	.	.	PUNCT
dpc-5766	15	1	orcid	orcid	PROPN
dpc-5766	15	2	id:0009	id:0009	NOUN
dpc-5766	15	3	-	-	PUNCT
dpc-5766	15	4	0005	0005	NUM
dpc-5766	15	5	-	-	PUNCT
dpc-5766	15	6	7478	7478	NUM
dpc-5766	15	7	-	-	PUNCT
dpc-5766	15	8	6856	6856	NUM
dpc-5766	15	9	.	.	PUNCT
dpc-5766	16	1	email	email	NOUN
dpc-5766	16	2	:	:	PUNCT
dpc-5766	16	3	eipaschou@auth.gr	eipaschou@auth.gr	VERB
dpc-5766	16	4	introduction	introduction	NOUN
dpc-5766	16	5	atopic	atopic	NOUN
dpc-5766	16	6	dermatitis	dermatitis	NOUN
dpc-5766	16	7	(	(	PUNCT
dpc-5766	16	8	ad	ad	NOUN
dpc-5766	16	9	)	)	PUNCT
dpc-5766	16	10	is	be	AUX
dpc-5766	16	11	the	the	DET
dpc-5766	16	12	most	most	ADV
dpc-5766	16	13	common	common	ADJ
dpc-5766	16	14	chronic	chronic	ADJ
dpc-5766	16	15	inflammatory	inflammatory	ADJ
dpc-5766	16	16	skin	skin	NOUN
dpc-5766	16	17	disease	disease	NOUN
dpc-5766	16	18	characterized	characterize	VERB
dpc-5766	16	19	by	by	ADP
dpc-5766	16	20	relapsing	relapse	VERB
dpc-5766	16	21	eczema	eczema	NOUN
dpc-5766	16	22	with	with	ADP
dpc-5766	16	23	intense	intense	ADJ
dpc-5766	16	24	pruritus	pruritus	NOUN
dpc-5766	16	25	,	,	PUNCT
dpc-5766	16	26	which	which	PRON
dpc-5766	16	27	greatly	greatly	ADV
dpc-5766	16	28	impacts	impact	VERB
dpc-5766	16	29	patients	patient	NOUN
dpc-5766	16	30	’	'	PUNCT
dpc-5766	16	31	quality	quality	NOUN
dpc-5766	16	32	of	of	ADP
dpc-5766	16	33	life	life	NOUN
dpc-5766	16	34	[	[	X
dpc-5766	16	35	1].while	1].while	NUM
dpc-5766	16	36	associations	association	NOUN
dpc-5766	16	37	between	between	ADP
dpc-5766	16	38	ad	ad	NOUN
dpc-5766	16	39	and	and	CCONJ
dpc-5766	16	40	allergic	allergic	ADJ
dpc-5766	16	41	conditions	condition	NOUN
dpc-5766	16	42	have	have	AUX
dpc-5766	16	43	been	be	AUX
dpc-5766	16	44	recognized	recognize	VERB
dpc-5766	16	45	for	for	ADP
dpc-5766	16	46	decades	decade	NOUN
dpc-5766	16	47	,	,	PUNCT
dpc-5766	16	48	numerous	numerous	ADJ
dpc-5766	16	49	non	non	ADJ
dpc-5766	16	50	allergic	allergic	ADJ
dpc-5766	16	51	comorbidities	comorbiditie	NOUN
dpc-5766	16	52	have	have	AUX
dpc-5766	16	53	also	also	ADV
dpc-5766	16	54	been	be	AUX
dpc-5766	16	55	identified	identify	VERB
dpc-5766	16	56	[	[	PUNCT
dpc-5766	16	57	2].however	2].however	NUM
dpc-5766	16	58	,	,	PUNCT
dpc-5766	16	59	treatment	treatment	NOUN
dpc-5766	16	60	guidelines	guideline	NOUN
dpc-5766	16	61	lack	lack	VERB
dpc-5766	16	62	high	high	ADJ
dpc-5766	16	63	-	-	PUNCT
dpc-5766	16	64	quality	quality	NOUN
dpc-5766	16	65	evidence	evidence	NOUN
dpc-5766	16	66	regarding	regard	VERB
dpc-5766	16	67	therapeutic	therapeutic	ADJ
dpc-5766	16	68	algorithms	algorithm	NOUN
dpc-5766	16	69	which	which	PRON
dpc-5766	16	70	consider	consider	VERB
dpc-5766	16	71	these	these	DET
dpc-5766	16	72	associations	association	NOUN
dpc-5766	16	73	[	[	X
dpc-5766	16	74	3	3	NUM
dpc-5766	16	75	]	]	PUNCT
dpc-5766	16	76	.	.	PUNCT
dpc-5766	17	1	this	this	DET
dpc-5766	17	2	study	study	NOUN
dpc-5766	17	3	presents	present	VERB
dpc-5766	17	4	real	real	ADJ
dpc-5766	17	5	-	-	PUNCT
dpc-5766	17	6	life	life	NOUN
dpc-5766	17	7	treatment	treatment	NOUN
dpc-5766	17	8	data	datum	NOUN
dpc-5766	17	9	for	for	ADP
dpc-5766	17	10	selected	select	VERB
dpc-5766	17	11	ad	ad	NOUN
dpc-5766	17	12	comorbidities	comorbiditie	NOUN
dpc-5766	17	13	.	.	PUNCT
dpc-5766	18	1	findings	finding	VERB
dpc-5766	18	2	a	a	DET
dpc-5766	18	3	retrospective	retrospective	ADJ
dpc-5766	18	4	observational	observational	ADJ
dpc-5766	18	5	study	study	NOUN
dpc-5766	18	6	was	be	AUX
dpc-5766	18	7	conducted	conduct	VERB
dpc-5766	18	8	at	at	ADP
dpc-5766	18	9	the	the	DET
dpc-5766	18	10	first	first	ADJ
dpc-5766	18	11	department	department	NOUN
dpc-5766	18	12	of	of	ADP
dpc-5766	18	13	dermatology	dermatology	NOUN
dpc-5766	18	14	and	and	CCONJ
dpc-5766	18	15	venereology	venereology	NOUN
dpc-5766	18	16	of	of	ADP
dpc-5766	18	17	aristotle	aristotle	PROPN
dpc-5766	18	18	university	university	PROPN
dpc-5766	18	19	,	,	PUNCT
dpc-5766	18	20	greece	greece	PROPN
dpc-5766	18	21	from	from	ADP
dpc-5766	18	22	april	april	PROPN
dpc-5766	18	23	2022	2022	NUM
dpc-5766	18	24	to	to	ADP
dpc-5766	18	25	may	may	PROPN
dpc-5766	18	26	2024	2024	NUM
dpc-5766	18	27	in	in	ADP
dpc-5766	18	28	compliance	compliance	NOUN
dpc-5766	18	29	with	with	ADP
dpc-5766	18	30	the	the	DET
dpc-5766	18	31	declaration	declaration	NOUN
dpc-5766	18	32	of	of	ADP
dpc-5766	18	33	helsinki	helsinki	PROPN
dpc-5766	18	34	.	.	PUNCT
dpc-5766	19	1	this	this	DET
dpc-5766	19	2	study	study	NOUN
dpc-5766	19	3	was	be	AUX
dpc-5766	19	4	approved	approve	VERB
dpc-5766	19	5	by	by	ADP
dpc-5766	19	6	the	the	DET
dpc-5766	19	7	bioethics	bioethics	PROPN
dpc-5766	19	8	committee	committee	NOUN
dpc-5766	19	9	(	(	PUNCT
dpc-5766	19	10	registry	registry	PROPN
dpc-5766	19	11	number	number	NOUN
dpc-5766	19	12	:	:	PUNCT
dpc-5766	19	13	3.651/18.01.2022	3.651/18.01.2022	NOUN
dpc-5766	19	14	)	)	PUNCT
dpc-5766	19	15	.	.	PUNCT
dpc-5766	20	1	written	write	VERB
dpc-5766	20	2	informed	informed	ADJ
dpc-5766	20	3	consent	consent	NOUN
dpc-5766	20	4	was	be	AUX
dpc-5766	20	5	obtained	obtain	VERB
dpc-5766	20	6	from	from	ADP
dpc-5766	20	7	adult	adult	NOUN
dpc-5766	20	8	participants	participant	NOUN
dpc-5766	20	9	(	(	PUNCT
dpc-5766	20	10	≥18	≥18	NUM
dpc-5766	20	11	years	year	NOUN
dpc-5766	20	12	)	)	PUNCT
dpc-5766	20	13	with	with	ADP
dpc-5766	20	14	clinically	clinically	ADV
dpc-5766	20	15	diagnosed	diagnose	VERB
dpc-5766	20	16	moderate	moderate	ADJ
dpc-5766	20	17	-	-	PUNCT
dpc-5766	20	18	to	to	ADP
dpc-5766	20	19	-	-	PUNCT
dpc-5766	20	20	severe	severe	ADJ
dpc-5766	20	21	ad	ad	NOUN
dpc-5766	20	22	according	accord	VERB
dpc-5766	20	23	to	to	ADP
dpc-5766	20	24	hanifin	hanifin	NOUN
dpc-5766	20	25	and	and	CCONJ
dpc-5766	20	26	rajka	rajka	NOUN
dpc-5766	20	27	criteria	criterion	NOUN
dpc-5766	20	28	who	who	PRON
dpc-5766	20	29	had	have	VERB
dpc-5766	20	30	at	at	ADV
dpc-5766	20	31	least	least	ADV
dpc-5766	20	32	one	one	NUM
dpc-5766	20	33	non	non	ADJ
dpc-5766	20	34	-	-	ADJ
dpc-5766	20	35	allergic	allergic	ADJ
dpc-5766	20	36	comorbidity	comorbidity	NOUN
dpc-5766	20	37	and	and	CCONJ
dpc-5766	20	38	complete	complete	ADJ
dpc-5766	20	39	electronic	electronic	ADJ
dpc-5766	20	40	medical	medical	ADJ
dpc-5766	20	41	records	record	NOUN
dpc-5766	20	42	available	available	ADJ
dpc-5766	20	43	for	for	ADP
dpc-5766	20	44	the	the	DET
dpc-5766	20	45	study	study	NOUN
dpc-5766	20	46	period	period	NOUN
dpc-5766	20	47	.	.	PUNCT
dpc-5766	21	1	non	non	ADJ
dpc-5766	21	2	-	-	ADJ
dpc-5766	21	3	qualifying	qualify	VERB
dpc-5766	21	4	patients	patient	NOUN
dpc-5766	21	5	were	be	AUX
dpc-5766	21	6	excluded	exclude	VERB
dpc-5766	21	7	.	.	PUNCT
dpc-5766	22	1	data	datum	NOUN
dpc-5766	22	2	were	be	AUX
dpc-5766	22	3	available	available	ADJ
dpc-5766	22	4	for	for	ADP
dpc-5766	22	5	50	50	NUM
dpc-5766	22	6	patients	patient	NOUN
dpc-5766	22	7	,	,	PUNCT
dpc-5766	22	8	27	27	NUM
dpc-5766	22	9	(	(	PUNCT
dpc-5766	22	10	54.0	54.0	NUM
dpc-5766	22	11	%	%	NOUN
dpc-5766	22	12	)	)	PUNCT
dpc-5766	22	13	males	male	NOUN
dpc-5766	22	14	and	and	CCONJ
dpc-5766	22	15	23	23	NUM
dpc-5766	22	16	(	(	PUNCT
dpc-5766	22	17	46.0	46.0	NUM
dpc-5766	22	18	%	%	NOUN
dpc-5766	22	19	)	)	PUNCT
dpc-5766	22	20	females	female	NOUN
dpc-5766	22	21	,	,	PUNCT
dpc-5766	22	22	with	with	ADP
dpc-5766	22	23	a	a	DET
dpc-5766	22	24	mean	mean	ADJ
dpc-5766	22	25	age	age	NOUN
dpc-5766	22	26	of	of	ADP
dpc-5766	22	27	39	39	NUM
dpc-5766	22	28	years	year	NOUN
dpc-5766	22	29	.	.	PUNCT
dpc-5766	23	1	patients	patient	NOUN
dpc-5766	23	2	were	be	AUX
dpc-5766	23	3	grouped	group	VERB
dpc-5766	23	4	according	accord	VERB
dpc-5766	23	5	to	to	ADP
dpc-5766	23	6	their	their	PRON
dpc-5766	23	7	comorbid	comorbid	NOUN
dpc-5766	23	8	condition	condition	NOUN
dpc-5766	23	9	.	.	PUNCT
dpc-5766	24	1	the	the	DET
dpc-5766	24	2	first	first	ADJ
dpc-5766	24	3	group	group	NOUN
dpc-5766	24	4	consisted	consist	VERB
dpc-5766	24	5	of	of	ADP
dpc-5766	24	6	those	those	PRON
dpc-5766	24	7	who	who	PRON
dpc-5766	24	8	exhibited	exhibit	VERB
dpc-5766	24	9	metabolic	metabolic	NOUN
dpc-5766	24	10	and	and	CCONJ
dpc-5766	24	11	cardiovascular	cardiovascular	ADJ
dpc-5766	24	12	diseases	disease	NOUN
dpc-5766	24	13	(	(	PUNCT
dpc-5766	24	14	cvd	cvd	PROPN
dpc-5766	24	15	)	)	PUNCT
dpc-5766	24	16	,	,	PUNCT
dpc-5766	24	17	28	28	NUM
dpc-5766	24	18	patients	patient	NOUN
dpc-5766	24	19	(	(	PUNCT
dpc-5766	24	20	56.0	56.0	NUM
dpc-5766	24	21	%	%	NOUN
dpc-5766	24	22	)	)	PUNCT
dpc-5766	24	23	(	(	PUNCT
dpc-5766	24	24	obesity	obesity	NOUN
dpc-5766	24	25	n=10	n=10	PRON
dpc-5766	24	26	,	,	PUNCT
dpc-5766	24	27	dyslipidemia	dyslipidemia	VERB
dpc-5766	24	28	n=5	n=5	PROPN
dpc-5766	24	29	,	,	PUNCT
dpc-5766	24	30	type	type	NOUN
dpc-5766	24	31	2	2	NUM
dpc-5766	24	32	diabetes	diabetes	NOUN
dpc-5766	24	33	n=2	n=2	ADV
dpc-5766	24	34	,	,	PUNCT
dpc-5766	24	35	hypertension	hypertension	NOUN
dpc-5766	24	36	n=6	n=6	NOUN
dpc-5766	24	37	,	,	PUNCT
dpc-5766	24	38	peripheral	peripheral	ADJ
dpc-5766	24	39	and	and	CCONJ
dpc-5766	24	40	coronary	coronary	ADJ
dpc-5766	24	41	artery	artery	NOUN
dpc-5766	24	42	disease	disease	NOUN
dpc-5766	24	43	n=3	n=3	PUNCT
dpc-5766	24	44	,	,	PUNCT
dpc-5766	24	45	deep	deep	ADJ
dpc-5766	24	46	vein	vein	ADJ
dpc-5766	24	47	thrombosis	thrombosis	NOUN
dpc-5766	24	48	n=1	n=1	PROPN
dpc-5766	24	49	,	,	PUNCT
dpc-5766	24	50	atrial	atrial	ADJ
dpc-5766	24	51	fibrillation	fibrillation	NOUN
dpc-5766	24	52	n=1	n=1	PROPN
dpc-5766	24	53	)	)	PUNCT
dpc-5766	24	54	.	.	PUNCT
dpc-5766	25	1	the	the	DET
dpc-5766	25	2	second	second	ADJ
dpc-5766	25	3	2	2	NUM
dpc-5766	25	4	research	research	NOUN
dpc-5766	25	5	letter	letter	NOUN
dpc-5766	25	6	|	|	ADV
dpc-5766	25	7	dermatol	dermatol	ADJ
dpc-5766	25	8	pract	pract	NOUN
dpc-5766	25	9	concept	concept	NOUN
dpc-5766	25	10	.	.	PUNCT
dpc-5766	26	1	2025;15(4):5766	2025;15(4):5766	NUM
dpc-5766	26	2	group	group	NOUN
dpc-5766	26	3	had	have	VERB
dpc-5766	26	4	immune	immune	NOUN
dpc-5766	26	5	-	-	PUNCT
dpc-5766	26	6	related	relate	VERB
dpc-5766	26	7	disorders	disorder	NOUN
dpc-5766	26	8	:	:	PUNCT
dpc-5766	26	9	19	19	NUM
dpc-5766	26	10	patients	patient	NOUN
dpc-5766	26	11	(	(	PUNCT
dpc-5766	26	12	38.0	38.0	NUM
dpc-5766	26	13	%	%	NOUN
dpc-5766	26	14	)	)	PUNCT
dpc-5766	26	15	(	(	PUNCT
dpc-5766	26	16	alopecia	alopecia	NOUN
dpc-5766	26	17	areata	areata	PROPN
dpc-5766	26	18	n=	n=	ADJ
dpc-5766	26	19	8	8	NUM
dpc-5766	26	20	,	,	PUNCT
dpc-5766	26	21	vitiligo	vitiligo	VERB
dpc-5766	26	22	n=2	n=2	ADV
dpc-5766	26	23	,	,	PUNCT
dpc-5766	26	24	chronic	chronic	ADJ
dpc-5766	26	25	urticaria	urticaria	NOUN
dpc-5766	26	26	n=2	n=2	ADV
dpc-5766	26	27	,	,	PUNCT
dpc-5766	26	28	rheumatoid	rheumatoid	VERB
dpc-5766	26	29	arthritis	arthritis	NOUN
dpc-5766	26	30	n=4	n=4	PROPN
dpc-5766	26	31	,	,	PUNCT
dpc-5766	26	32	systemic	systemic	ADJ
dpc-5766	26	33	lupus	lupus	PROPN
dpc-5766	26	34	erythematosus	erythematosus	PROPN
dpc-5766	26	35	n=1	n=1	PROPN
dpc-5766	26	36	,	,	PUNCT
dpc-5766	26	37	psoriasis	psoriasis	NOUN
dpc-5766	26	38	n=1	n=1	PROPN
dpc-5766	26	39	,	,	PUNCT
dpc-5766	26	40	inflammatory	inflammatory	ADJ
dpc-5766	26	41	bowel	bowel	NOUN
dpc-5766	26	42	disease	disease	NOUN
dpc-5766	26	43	n=1	n=1	PROPN
dpc-5766	26	44	)	)	PUNCT
dpc-5766	26	45	,	,	PUNCT
dpc-5766	26	46	and	and	CCONJ
dpc-5766	26	47	the	the	DET
dpc-5766	26	48	third	third	ADJ
dpc-5766	26	49	had	have	VERB
dpc-5766	26	50	bone	bone	NOUN
dpc-5766	26	51	health	health	NOUN
dpc-5766	26	52	conditions	condition	NOUN
dpc-5766	26	53	:	:	PUNCT
dpc-5766	26	54	three	three	NUM
dpc-5766	26	55	patients	patient	NOUN
dpc-5766	26	56	(	(	PUNCT
dpc-5766	26	57	6.0	6.0	NUM
dpc-5766	26	58	%	%	NOUN
dpc-5766	26	59	)	)	PUNCT
dpc-5766	26	60	(	(	PUNCT
dpc-5766	26	61	osteoporosis	osteoporosis	NOUN
dpc-5766	26	62	n=2	n=2	ADV
dpc-5766	26	63	,	,	PUNCT
dpc-5766	26	64	osteoporotic	osteoporotic	ADJ
dpc-5766	26	65	bone	bone	NOUN
dpc-5766	26	66	fractures	fracture	NOUN
dpc-5766	26	67	n=1	n=1	PROPN
dpc-5766	26	68	)	)	PUNCT
dpc-5766	26	69	.	.	PUNCT
dpc-5766	27	1	treatment	treatment	NOUN
dpc-5766	27	2	decisions	decision	NOUN
dpc-5766	27	3	were	be	AUX
dpc-5766	27	4	made	make	VERB
dpc-5766	27	5	using	use	VERB
dpc-5766	27	6	scorad	scorad	NOUN
dpc-5766	27	7	(	(	PUNCT
dpc-5766	27	8	scoring	score	VERB
dpc-5766	27	9	atopic	atopic	NOUN
dpc-5766	27	10	dermatitis	dermatitis	NOUN
dpc-5766	27	11	)	)	PUNCT
dpc-5766	27	12	,	,	PUNCT
dpc-5766	27	13	easi	easi	NOUN
dpc-5766	27	14	(	(	PUNCT
dpc-5766	27	15	eczema	eczema	NOUN
dpc-5766	27	16	area	area	NOUN
dpc-5766	27	17	and	and	CCONJ
dpc-5766	27	18	severity	severity	NOUN
dpc-5766	27	19	index	index	NOUN
dpc-5766	27	20	)	)	PUNCT
dpc-5766	27	21	,	,	PUNCT
dpc-5766	27	22	and	and	CCONJ
dpc-5766	27	23	iga	iga	PROPN
dpc-5766	27	24	(	(	PUNCT
dpc-5766	27	25	investigator	investigator	NOUN
dpc-5766	27	26	’s	’s	PART
dpc-5766	27	27	global	global	ADJ
dpc-5766	27	28	assessment	assessment	NOUN
dpc-5766	27	29	scale	scale	NOUN
dpc-5766	27	30	)	)	PUNCT
dpc-5766	27	31	scoring	scoring	NOUN
dpc-5766	27	32	systems	system	NOUN
dpc-5766	27	33	,	,	PUNCT
dpc-5766	27	34	considering	consider	VERB
dpc-5766	27	35	age	age	NOUN
dpc-5766	27	36	,	,	PUNCT
dpc-5766	27	37	sex	sex	NOUN
dpc-5766	27	38	,	,	PUNCT
dpc-5766	27	39	and	and	CCONJ
dpc-5766	27	40	comorbidities	comorbiditie	NOUN
dpc-5766	27	41	through	through	ADP
dpc-5766	27	42	multidisciplinary	multidisciplinary	ADJ
dpc-5766	27	43	consultation	consultation	NOUN
dpc-5766	27	44	when	when	SCONJ
dpc-5766	27	45	appropriate	appropriate	ADJ
dpc-5766	27	46	.	.	PUNCT
dpc-5766	28	1	for	for	ADP
dpc-5766	28	2	moderate	moderate	ADJ
dpc-5766	28	3	-	-	PUNCT
dpc-5766	28	4	to	to	ADP
dpc-5766	28	5	-	-	PUNCT
dpc-5766	28	6	severe	severe	ADJ
dpc-5766	28	7	disease	disease	NOUN
dpc-5766	28	8	,	,	PUNCT
dpc-5766	28	9	phototherapy	phototherapy	NOUN
dpc-5766	28	10	,	,	PUNCT
dpc-5766	28	11	predominantly	predominantly	ADV
dpc-5766	28	12	narrowband	narrowband	VERB
dpc-5766	28	13	uvb	uvb	ADJ
dpc-5766	28	14	,	,	PUNCT
dpc-5766	28	15	and	and	CCONJ
dpc-5766	28	16	less	less	ADV
dpc-5766	28	17	frequently	frequently	ADV
dpc-5766	28	18	uva1	uva1	PROPN
dpc-5766	28	19	,	,	PUNCT
dpc-5766	28	20	administered	administer	VERB
dpc-5766	28	21	three	three	NUM
dpc-5766	28	22	times	time	NOUN
dpc-5766	28	23	per	per	ADP
dpc-5766	28	24	week	week	NOUN
dpc-5766	28	25	for	for	ADP
dpc-5766	28	26	six	six	NUM
dpc-5766	28	27	months	month	NOUN
dpc-5766	28	28	,	,	PUNCT
dpc-5766	28	29	was	be	AUX
dpc-5766	28	30	the	the	DET
dpc-5766	28	31	most	most	ADV
dpc-5766	28	32	commonly	commonly	ADV
dpc-5766	28	33	used	use	VERB
dpc-5766	28	34	treatment	treatment	NOUN
dpc-5766	28	35	in	in	ADP
dpc-5766	28	36	cvd	cvd	PROPN
dpc-5766	28	37	patients	patient	NOUN
dpc-5766	28	38	.	.	PUNCT
dpc-5766	29	1	for	for	ADP
dpc-5766	29	2	relapsing	relapse	VERB
dpc-5766	29	3	disease	disease	NOUN
dpc-5766	29	4	,	,	PUNCT
dpc-5766	29	5	dupilumab	dupilumab	NOUN
dpc-5766	29	6	was	be	AUX
dpc-5766	29	7	chosen	choose	VERB
dpc-5766	29	8	due	due	ADP
dpc-5766	29	9	to	to	ADP
dpc-5766	29	10	its	its	PRON
dpc-5766	29	11	safety	safety	NOUN
dpc-5766	29	12	profile	profile	NOUN
dpc-5766	29	13	.	.	PUNCT
dpc-5766	30	1	for	for	ADP
dpc-5766	30	2	immune	immune	NOUN
dpc-5766	30	3	-	-	PUNCT
dpc-5766	30	4	mediated	mediate	VERB
dpc-5766	30	5	disorders	disorder	NOUN
dpc-5766	30	6	,	,	PUNCT
dpc-5766	30	7	biologics	biologic	NOUN
dpc-5766	30	8	and	and	CCONJ
dpc-5766	30	9	small	small	ADJ
dpc-5766	30	10	molecules	molecule	NOUN
dpc-5766	30	11	were	be	AUX
dpc-5766	30	12	prescribed	prescribe	VERB
dpc-5766	30	13	more	more	ADV
dpc-5766	30	14	frequently	frequently	ADV
dpc-5766	30	15	.	.	PUNCT
dpc-5766	31	1	in	in	ADP
dpc-5766	31	2	the	the	DET
dpc-5766	31	3	bone	bone	NOUN
dpc-5766	31	4	health	health	NOUN
dpc-5766	31	5	group	group	NOUN
dpc-5766	31	6	,	,	PUNCT
dpc-5766	31	7	systemic	systemic	ADJ
dpc-5766	31	8	corticosteroids	corticosteroid	NOUN
dpc-5766	31	9	and	and	CCONJ
dpc-5766	31	10	cyclosporine	cyclosporine	NOUN
dpc-5766	31	11	were	be	AUX
dpc-5766	31	12	excluded	exclude	VERB
dpc-5766	31	13	due	due	ADP
dpc-5766	31	14	to	to	ADP
dpc-5766	31	15	negative	negative	ADJ
dpc-5766	31	16	bone	bone	NOUN
dpc-5766	31	17	effects	effect	NOUN
dpc-5766	31	18	.	.	PUNCT
dpc-5766	32	1	targeted	target	VERB
dpc-5766	32	2	therapies	therapy	NOUN
dpc-5766	32	3	were	be	AUX
dpc-5766	32	4	initiated	initiate	VERB
dpc-5766	32	5	more	more	ADV
dpc-5766	32	6	frequently	frequently	ADV
dpc-5766	32	7	.	.	PUNCT
dpc-5766	33	1	systematic	systematic	ADJ
dpc-5766	33	2	agents	agent	NOUN
dpc-5766	33	3	are	be	AUX
dpc-5766	33	4	summarized	summarize	VERB
dpc-5766	33	5	in	in	ADP
dpc-5766	33	6	table	table	NOUN
dpc-5766	33	7	1	1	NUM
dpc-5766	33	8	.	.	PUNCT
dpc-5766	34	1	all	all	DET
dpc-5766	34	2	treatments	treatment	NOUN
dpc-5766	34	3	were	be	AUX
dpc-5766	34	4	combined	combine	VERB
dpc-5766	34	5	with	with	ADP
dpc-5766	34	6	topical	topical	ADJ
dpc-5766	34	7	mild	mild	ADJ
dpc-5766	34	8	-	-	PUNCT
dpc-5766	34	9	to	to	ADP
dpc-5766	34	10	-	-	PUNCT
dpc-5766	34	11	moderate	moderate	ADJ
dpc-5766	34	12	corticosteroids	corticosteroid	NOUN
dpc-5766	34	13	.	.	PUNCT
dpc-5766	35	1	no	no	DET
dpc-5766	35	2	serious	serious	ADJ
dpc-5766	35	3	adverse	adverse	ADJ
dpc-5766	35	4	event	event	NOUN
dpc-5766	35	5	was	be	AUX
dpc-5766	35	6	identified	identify	VERB
dpc-5766	35	7	during	during	ADP
dpc-5766	35	8	the	the	DET
dpc-5766	35	9	26	26	NUM
dpc-5766	35	10	-	-	PUNCT
dpc-5766	35	11	month	month	NOUN
dpc-5766	35	12	follow	follow	NOUN
dpc-5766	35	13	-	-	PUNCT
dpc-5766	35	14	up	up	NOUN
dpc-5766	35	15	.	.	PUNCT
dpc-5766	36	1	conclusion	conclusion	NOUN
dpc-5766	36	2	our	our	PRON
dpc-5766	36	3	findings	finding	NOUN
dpc-5766	36	4	align	align	VERB
dpc-5766	36	5	with	with	ADP
dpc-5766	36	6	recent	recent	ADJ
dpc-5766	36	7	epidemiological	epidemiological	ADJ
dpc-5766	36	8	studies	study	NOUN
dpc-5766	36	9	demonstrating	demonstrate	VERB
dpc-5766	36	10	high	high	ADJ
dpc-5766	36	11	prevalence	prevalence	NOUN
dpc-5766	36	12	of	of	ADP
dpc-5766	36	13	cvd	cvd	PROPN
dpc-5766	36	14	and	and	CCONJ
dpc-5766	36	15	autoimmune	autoimmune	ADJ
dpc-5766	36	16	comorbidities	comorbiditie	NOUN
dpc-5766	36	17	in	in	ADP
dpc-5766	36	18	ad	ad	NOUN
dpc-5766	36	19	patients	patient	NOUN
dpc-5766	36	20	,	,	PUNCT
dpc-5766	36	21	reflecting	reflect	VERB
dpc-5766	36	22	ad	ad	NOUN
dpc-5766	36	23	’s	’s	PART
dpc-5766	36	24	systemic	systemic	ADJ
dpc-5766	36	25	inflammatory	inflammatory	ADJ
dpc-5766	36	26	nature	nature	NOUN
dpc-5766	37	1	[	[	X
dpc-5766	37	2	4	4	NUM
dpc-5766	37	3	]	]	PUNCT
dpc-5766	37	4	.	.	PUNCT
dpc-5766	38	1	dermatologists	dermatologist	NOUN
dpc-5766	38	2	’	'	PUNCT
dpc-5766	38	3	choices	choice	NOUN
dpc-5766	38	4	in	in	ADP
dpc-5766	38	5	our	our	PRON
dpc-5766	38	6	study	study	NOUN
dpc-5766	38	7	are	be	AUX
dpc-5766	38	8	greatly	greatly	ADV
dpc-5766	38	9	dependent	dependent	ADJ
dpc-5766	38	10	on	on	ADP
dpc-5766	38	11	disease	disease	NOUN
dpc-5766	38	12	activity	activity	NOUN
dpc-5766	38	13	and	and	CCONJ
dpc-5766	38	14	comorbid	comorbid	NOUN
dpc-5766	38	15	conditions	condition	NOUN
dpc-5766	38	16	.	.	PUNCT
dpc-5766	39	1	while	while	SCONJ
dpc-5766	39	2	international	international	ADJ
dpc-5766	39	3	recommendations	recommendation	NOUN
dpc-5766	39	4	emphasize	emphasize	VERB
dpc-5766	39	5	systemic	systemic	ADJ
dpc-5766	39	6	immunosuppression	immunosuppression	NOUN
dpc-5766	39	7	for	for	ADP
dpc-5766	39	8	severe	severe	ADJ
dpc-5766	39	9	ad	ad	NOUN
dpc-5766	39	10	,	,	PUNCT
dpc-5766	39	11	our	our	PRON
dpc-5766	39	12	real	real	ADJ
dpc-5766	39	13	-	-	PUNCT
dpc-5766	39	14	world	world	NOUN
dpc-5766	39	15	data	datum	NOUN
dpc-5766	39	16	show	show	VERB
dpc-5766	39	17	a	a	DET
dpc-5766	39	18	cautious	cautious	ADJ
dpc-5766	39	19	,	,	PUNCT
dpc-5766	39	20	personalized	personalized	ADJ
dpc-5766	39	21	approach	approach	NOUN
dpc-5766	39	22	in	in	ADP
dpc-5766	39	23	cvd	cvd	PROPN
dpc-5766	39	24	patients	patient	NOUN
dpc-5766	39	25	.	.	PUNCT
dpc-5766	40	1	the	the	DET
dpc-5766	40	2	predominant	predominant	ADJ
dpc-5766	40	3	use	use	NOUN
dpc-5766	40	4	of	of	ADP
dpc-5766	40	5	phototherapy	phototherapy	NOUN
dpc-5766	40	6	reflects	reflect	VERB
dpc-5766	40	7	safety	safety	NOUN
dpc-5766	40	8	considerations	consideration	NOUN
dpc-5766	40	9	in	in	ADP
dpc-5766	40	10	clinical	clinical	ADJ
dpc-5766	40	11	practice	practice	NOUN
dpc-5766	40	12	.	.	PUNCT
dpc-5766	41	1	the	the	DET
dpc-5766	41	2	use	use	NOUN
dpc-5766	41	3	of	of	ADP
dpc-5766	41	4	jak	jak	PROPN
dpc-5766	41	5	inhibitors	inhibitor	NOUN
dpc-5766	41	6	for	for	ADP
dpc-5766	41	7	autoimmune	autoimmune	ADJ
dpc-5766	41	8	conditions	condition	NOUN
dpc-5766	41	9	in	in	ADP
dpc-5766	41	10	our	our	PRON
dpc-5766	41	11	cohort	cohort	NOUN
dpc-5766	41	12	is	be	AUX
dpc-5766	41	13	consistent	consistent	ADJ
dpc-5766	41	14	with	with	ADP
dpc-5766	41	15	recommendations	recommendation	NOUN
dpc-5766	41	16	[	[	X
dpc-5766	41	17	5	5	NUM
dpc-5766	41	18	]	]	PUNCT
dpc-5766	41	19	.	.	PUNCT
dpc-5766	42	1	our	our	PRON
dpc-5766	42	2	preference	preference	NOUN
dpc-5766	42	3	for	for	ADP
dpc-5766	42	4	dupilumab	dupilumab	NOUN
dpc-5766	42	5	across	across	ADP
dpc-5766	42	6	all	all	DET
dpc-5766	42	7	comorbidity	comorbidity	NOUN
dpc-5766	42	8	groups	group	NOUN
dpc-5766	42	9	aligns	align	VERB
dpc-5766	42	10	with	with	ADP
dpc-5766	42	11	real	real	ADJ
dpc-5766	42	12	-	-	PUNCT
dpc-5766	42	13	world	world	NOUN
dpc-5766	42	14	effectiveness	effectiveness	NOUN
dpc-5766	42	15	studies	study	NOUN
dpc-5766	42	16	regarding	regard	VERB
dpc-5766	42	17	cardiovascular	cardiovascular	ADJ
dpc-5766	42	18	safety	safety	NOUN
dpc-5766	42	19	[	[	X
dpc-5766	42	20	6	6	NUM
dpc-5766	42	21	]	]	PUNCT
dpc-5766	42	22	.	.	PUNCT
dpc-5766	43	1	future	future	ADJ
dpc-5766	43	2	studies	study	NOUN
dpc-5766	43	3	are	be	AUX
dpc-5766	43	4	needed	need	VERB
dpc-5766	43	5	to	to	PART
dpc-5766	43	6	establish	establish	VERB
dpc-5766	43	7	evidence	evidence	NOUN
dpc-5766	43	8	-	-	PUNCT
dpc-5766	43	9	based	base	VERB
dpc-5766	43	10	treatment	treatment	NOUN
dpc-5766	43	11	algorithms	algorithm	NOUN
dpc-5766	43	12	for	for	ADP
dpc-5766	43	13	ad	ad	NOUN
dpc-5766	43	14	patients	patient	NOUN
dpc-5766	43	15	with	with	ADP
dpc-5766	43	16	specific	specific	ADJ
dpc-5766	43	17	comorbidity	comorbidity	NOUN
dpc-5766	43	18	profiles	profile	NOUN
dpc-5766	43	19	.	.	PUNCT
dpc-5766	44	1	ethical	ethical	ADJ
dpc-5766	44	2	approval	approval	NOUN
dpc-5766	44	3	:	:	PUNCT
dpc-5766	44	4	this	this	DET
dpc-5766	44	5	study	study	NOUN
dpc-5766	44	6	was	be	AUX
dpc-5766	44	7	approved	approve	VERB
dpc-5766	44	8	by	by	ADP
dpc-5766	44	9	the	the	DET
dpc-5766	44	10	bioethics	bioethics	PROPN
dpc-5766	44	11	committee	committee	NOUN
dpc-5766	44	12	of	of	ADP
dpc-5766	44	13	the	the	DET
dpc-5766	44	14	medical	medical	ADJ
dpc-5766	44	15	school	school	NOUN
dpc-5766	44	16	of	of	ADP
dpc-5766	44	17	aristotle	aristotle	PROPN
dpc-5766	44	18	university	university	PROPN
dpc-5766	44	19	of	of	ADP
dpc-5766	44	20	thessaloniki	thessaloniki	PROPN
dpc-5766	44	21	,	,	PUNCT
dpc-5766	44	22	greece	greece	PROPN
dpc-5766	44	23	(	(	PUNCT
dpc-5766	44	24	registry	registry	PROPN
dpc-5766	44	25	number	number	NOUN
dpc-5766	44	26	:	:	PUNCT
dpc-5766	44	27	3.651/18.01.2022	3.651/18.01.2022	NOUN
dpc-5766	44	28	)	)	PUNCT
dpc-5766	44	29	.	.	PUNCT
dpc-5766	45	1	the	the	DET
dpc-5766	45	2	research	research	NOUN
dpc-5766	45	3	process	process	NOUN
dpc-5766	45	4	complied	comply	VERB
dpc-5766	45	5	with	with	ADP
dpc-5766	45	6	the	the	DET
dpc-5766	45	7	declaration	declaration	NOUN
dpc-5766	45	8	of	of	ADP
dpc-5766	45	9	helsinki	helsinki	PROPN
dpc-5766	45	10	.	.	PUNCT
dpc-5766	46	1	written	write	VERB
dpc-5766	46	2	informed	informed	ADJ
dpc-5766	46	3	consent	consent	NOUN
dpc-5766	46	4	was	be	AUX
dpc-5766	46	5	obtained	obtain	VERB
dpc-5766	46	6	from	from	ADP
dpc-5766	46	7	all	all	DET
dpc-5766	46	8	patients	patient	NOUN
dpc-5766	46	9	.	.	PUNCT
dpc-5766	47	1	table	table	NOUN
dpc-5766	47	2	1	1	NUM
dpc-5766	47	3	.	.	PUNCT
dpc-5766	47	4	treatment	treatment	NOUN
dpc-5766	47	5	choices	choice	NOUN
dpc-5766	47	6	for	for	ADP
dpc-5766	47	7	patients	patient	NOUN
dpc-5766	47	8	exhibiting	exhibit	VERB
dpc-5766	47	9	non	non	ADJ
dpc-5766	47	10	-	-	ADJ
dpc-5766	47	11	allergic	allergic	ADJ
dpc-5766	47	12	comorbidities	comorbiditie	NOUN
dpc-5766	47	13	.	.	PUNCT
dpc-5766	48	1	treatment	treatment	NOUN
dpc-5766	48	2	dose	dose	NOUN
dpc-5766	48	3	metabolic	metabolic	NOUN
dpc-5766	48	4	and	and	CCONJ
dpc-5766	48	5	cardiovascular	cardiovascular	ADJ
dpc-5766	48	6	comorbidities	comorbiditie	NOUN
dpc-5766	48	7	immune	immune	NOUN
dpc-5766	48	8	-	-	PUNCT
dpc-5766	48	9	mediated	mediate	VERB
dpc-5766	48	10	comorbidities	comorbiditie	NOUN
dpc-5766	48	11	osteoporosis	osteoporosis	VERB
dpc-5766	48	12	percentage	percentage	NOUN
dpc-5766	48	13	%	%	NOUN
dpc-5766	48	14	a	a	DET
dpc-5766	48	15	(	(	PUNCT
dpc-5766	48	16	n)b	n)b	ADJ
dpc-5766	48	17	percentage	percentage	NOUN
dpc-5766	48	18	%	%	NOUN
dpc-5766	48	19	(	(	PUNCT
dpc-5766	48	20	n	n	CCONJ
dpc-5766	48	21	)	)	PUNCT
dpc-5766	48	22	percentage	percentage	NOUN
dpc-5766	48	23	%	%	NOUN
dpc-5766	48	24	(	(	PUNCT
dpc-5766	48	25	n	n	CCONJ
dpc-5766	48	26	)	)	PUNCT
dpc-5766	48	27	phototherapy	phototherapy	NOUN
dpc-5766	48	28	nb	nb	PROPN
dpc-5766	48	29	-	-	PUNCT
dpc-5766	48	30	uvbc	uvbc	ADJ
dpc-5766	48	31	2	2	NUM
dpc-5766	48	32	or	or	CCONJ
dpc-5766	48	33	3	3	NUM
dpc-5766	48	34	times	time	NOUN
dpc-5766	48	35	per	per	ADP
dpc-5766	48	36	week	week	NOUN
dpc-5766	48	37	57.1	57.1	NUM
dpc-5766	48	38	%	%	NOUN
dpc-5766	48	39	(	(	PUNCT
dpc-5766	48	40	16	16	NUM
dpc-5766	48	41	)	)	PUNCT
dpc-5766	48	42	uva1d	uva1d	PROPN
dpc-5766	48	43	2	2	NUM
dpc-5766	48	44	or	or	CCONJ
dpc-5766	48	45	3	3	NUM
dpc-5766	48	46	times	time	NOUN
dpc-5766	48	47	per	per	ADP
dpc-5766	48	48	week	week	NOUN
dpc-5766	48	49	17.8	17.8	NUM
dpc-5766	48	50	%	%	NOUN
dpc-5766	48	51	(	(	PUNCT
dpc-5766	48	52	5	5	NUM
dpc-5766	48	53	)	)	PUNCT
dpc-5766	48	54	systemics	systemic	NOUN
dpc-5766	48	55	corticosteroids	corticosteroid	NOUN
dpc-5766	48	56	0.35	0.35	NUM
dpc-5766	48	57	-	-	SYM
dpc-5766	48	58	1	1	NUM
dpc-5766	48	59	mg	mg	PROPN
dpc-5766	48	60	/	/	SYM
dpc-5766	48	61	kg	kg	NOUN
dpc-5766	48	62	per	per	ADP
dpc-5766	48	63	day	day	NOUN
dpc-5766	48	64	10.5	10.5	NUM
dpc-5766	48	65	%	%	NOUN
dpc-5766	48	66	(	(	PUNCT
dpc-5766	48	67	2	2	NUM
dpc-5766	48	68	)	)	PUNCT
dpc-5766	48	69	cyclosporine	cyclosporine	NOUN
dpc-5766	48	70	(	(	PUNCT
dpc-5766	48	71	cya	cya	NOUN
dpc-5766	48	72	)	)	PUNCT
dpc-5766	48	73	2.5	2.5	NUM
dpc-5766	48	74	-	-	SYM
dpc-5766	48	75	5	5	NUM
dpc-5766	48	76	mg	mg	PROPN
dpc-5766	48	77	/	/	SYM
dpc-5766	48	78	kg	kg	NOUN
dpc-5766	48	79	per	per	ADP
dpc-5766	48	80	day	day	NOUN
dpc-5766	48	81	3.6	3.6	NUM
dpc-5766	48	82	%	%	NOUN
dpc-5766	48	83	(	(	PUNCT
dpc-5766	48	84	1	1	NUM
dpc-5766	48	85	)	)	PUNCT
dpc-5766	48	86	21.1	21.1	NUM
dpc-5766	48	87	%	%	NOUN
dpc-5766	48	88	(	(	PUNCT
dpc-5766	48	89	4	4	NUM
dpc-5766	48	90	)	)	PUNCT
dpc-5766	48	91	methotrexate	methotrexate	NOUN
dpc-5766	48	92	(	(	PUNCT
dpc-5766	48	93	mtx	mtx	NOUN
dpc-5766	48	94	)	)	PUNCT
dpc-5766	48	95	5	5	NUM
dpc-5766	48	96	-	-	SYM
dpc-5766	48	97	15	15	NUM
dpc-5766	48	98	mg	mg	NOUN
dpc-5766	48	99	per	per	ADP
dpc-5766	48	100	week	week	NOUN
dpc-5766	48	101	3.6	3.6	NUM
dpc-5766	48	102	%	%	NOUN
dpc-5766	48	103	(	(	PUNCT
dpc-5766	48	104	1	1	NUM
dpc-5766	48	105	)	)	PUNCT
dpc-5766	48	106	azathioprine	azathioprine	NOUN
dpc-5766	48	107	(	(	PUNCT
dpc-5766	48	108	aza	aza	NOUN
dpc-5766	48	109	)	)	PUNCT
dpc-5766	48	110	1	1	NUM
dpc-5766	48	111	-	-	SYM
dpc-5766	48	112	3	3	NUM
dpc-5766	48	113	mg	mg	PROPN
dpc-5766	48	114	/	/	SYM
dpc-5766	48	115	kg	kg	NOUN
dpc-5766	48	116	per	per	ADP
dpc-5766	48	117	day	day	NOUN
dpc-5766	48	118	5.3	5.3	NUM
dpc-5766	48	119	%	%	NOUN
dpc-5766	48	120	(	(	PUNCT
dpc-5766	48	121	1	1	NUM
dpc-5766	48	122	)	)	PUNCT
dpc-5766	48	123	dupilumab	dupilumab	NOUN
dpc-5766	48	124	600	600	NUM
dpc-5766	48	125	mg	mg	NOUN
dpc-5766	48	126	s.c	s.c	PROPN
dpc-5766	48	127	day	day	NOUN
dpc-5766	48	128	1	1	NUM
dpc-5766	48	129	followed	follow	VERB
dpc-5766	48	130	by	by	ADP
dpc-5766	48	131	300	300	NUM
dpc-5766	48	132	mg	mg	PROPN
dpc-5766	48	133	q2w	q2w	NOUN
dpc-5766	48	134	17.9	17.9	NUM
dpc-5766	48	135	%	%	NOUN
dpc-5766	48	136	(	(	PUNCT
dpc-5766	48	137	5	5	NUM
dpc-5766	48	138	)	)	PUNCT
dpc-5766	48	139	10.5	10.5	NUM
dpc-5766	48	140	%	%	NOUN
dpc-5766	48	141	(	(	PUNCT
dpc-5766	48	142	2	2	NUM
dpc-5766	48	143	)	)	PUNCT
dpc-5766	48	144	66.7	66.7	NUM
dpc-5766	48	145	%	%	NOUN
dpc-5766	48	146	(	(	PUNCT
dpc-5766	48	147	2	2	NUM
dpc-5766	48	148	)	)	PUNCT
dpc-5766	48	149	baricitinib	baricitinib	NOUN
dpc-5766	48	150	4	4	NUM
dpc-5766	48	151	mg	mg	NOUN
dpc-5766	48	152	or	or	CCONJ
dpc-5766	48	153	2	2	NUM
dpc-5766	48	154	mg	mg	NOUN
dpc-5766	48	155	per	per	ADP
dpc-5766	48	156	day	day	NOUN
dpc-5766	48	157	26.3	26.3	NUM
dpc-5766	48	158	%	%	NOUN
dpc-5766	48	159	(	(	PUNCT
dpc-5766	48	160	5	5	NUM
dpc-5766	48	161	)	)	PUNCT
dpc-5766	48	162	upadacitinib	upadacitinib	NOUN
dpc-5766	48	163	30	30	NUM
dpc-5766	48	164	mg	mg	NOUN
dpc-5766	48	165	or	or	CCONJ
dpc-5766	48	166	15	15	NUM
dpc-5766	48	167	mg	mg	NOUN
dpc-5766	48	168	per	per	ADP
dpc-5766	48	169	day	day	NOUN
dpc-5766	48	170	26.3	26.3	NUM
dpc-5766	48	171	%	%	NOUN
dpc-5766	48	172	(	(	PUNCT
dpc-5766	48	173	5	5	NUM
dpc-5766	48	174	)	)	PUNCT
dpc-5766	48	175	abrocitinib	abrocitinib	NOUN
dpc-5766	48	176	200	200	NUM
dpc-5766	48	177	mg	mg	NOUN
dpc-5766	48	178	or	or	CCONJ
dpc-5766	48	179	100	100	NUM
dpc-5766	48	180	mg	mg	ADP
dpc-5766	48	181	per	per	ADP
dpc-5766	48	182	day	day	NOUN
dpc-5766	48	183	33.3	33.3	NUM
dpc-5766	48	184	%	%	NOUN
dpc-5766	48	185	(	(	PUNCT
dpc-5766	48	186	1	1	NUM
dpc-5766	48	187	)	)	PUNCT
dpc-5766	48	188	a.	a.	NOUN
dpc-5766	48	189	percentage	percentage	NOUN
dpc-5766	48	190	(	(	PUNCT
dpc-5766	48	191	%	%	INTJ
dpc-5766	48	192	):	):	PUNCT
dpc-5766	48	193	percentage	percentage	NOUN
dpc-5766	48	194	of	of	ADP
dpc-5766	48	195	patients	patient	NOUN
dpc-5766	48	196	receiving	receive	VERB
dpc-5766	48	197	this	this	DET
dpc-5766	48	198	treatment	treatment	NOUN
dpc-5766	48	199	from	from	ADP
dpc-5766	48	200	each	each	DET
dpc-5766	48	201	group	group	NOUN
dpc-5766	48	202	;	;	PUNCT
dpc-5766	48	203	b.	b.	PROPN
dpc-5766	48	204	(	(	PUNCT
dpc-5766	48	205	n	n	CCONJ
dpc-5766	48	206	):	):	PUNCT
dpc-5766	48	207	number	number	NOUN
dpc-5766	48	208	of	of	ADP
dpc-5766	48	209	patients	patient	NOUN
dpc-5766	48	210	receiving	receive	VERB
dpc-5766	48	211	this	this	DET
dpc-5766	48	212	treatment	treatment	NOUN
dpc-5766	48	213	.	.	PUNCT
dpc-5766	49	1	;	;	PUNCT
dpc-5766	49	2	c.	c.	PROPN
dpc-5766	49	3	nb	nb	PROPN
dpc-5766	49	4	-	-	PUNCT
dpc-5766	49	5	uvb	uvb	ADJ
dpc-5766	49	6	:	:	PUNCT
dpc-5766	49	7	narrow	narrow	ADJ
dpc-5766	49	8	-	-	PUNCT
dpc-5766	49	9	band	band	NOUN
dpc-5766	49	10	ultraviolet	ultraviolet	PROPN
dpc-5766	49	11	b.	b.	PROPN
dpc-5766	49	12	;	;	PUNCT
dpc-5766	49	13	d.	d.	PROPN
dpc-5766	49	14	uva1	uva1	PROPN
dpc-5766	49	15	:	:	PUNCT
dpc-5766	49	16	ultraviolet	ultraviolet	ADJ
dpc-5766	49	17	a1	a1	PROPN
dpc-5766	49	18	.	.	PROPN
dpc-5766	49	19	research	research	NOUN
dpc-5766	49	20	letter	letter	NOUN
dpc-5766	50	1	|	|	ADV
dpc-5766	50	2	dermatol	dermatol	ADJ
dpc-5766	50	3	pract	pract	NOUN
dpc-5766	50	4	concept	concept	NOUN
dpc-5766	50	5	.	.	PUNCT
dpc-5766	51	1	2025;15(4):5766	2025;15(4):5766	NUM
dpc-5766	51	2	3	3	NUM
dpc-5766	51	3	references	reference	NOUN
dpc-5766	51	4	1	1	NUM
dpc-5766	51	5	.	.	PUNCT
dpc-5766	52	1	silverberg	silverberg	PROPN
dpc-5766	52	2	ji	ji	PROPN
dpc-5766	52	3	.	.	PROPN
dpc-5766	52	4	public	public	ADJ
dpc-5766	52	5	health	health	NOUN
dpc-5766	52	6	burden	burden	NOUN
dpc-5766	52	7	and	and	CCONJ
dpc-5766	52	8	epidemiology	epidemiology	NOUN
dpc-5766	52	9	of	of	ADP
dpc-5766	52	10	atopic	atopic	NOUN
dpc-5766	52	11	dermatitis	dermatitis	NOUN
dpc-5766	52	12	.	.	PUNCT
dpc-5766	53	1	dermatol	dermatol	NOUN
dpc-5766	53	2	clin	clin	PROPN
dpc-5766	53	3	.	.	PUNCT
dpc-5766	54	1	2017	2017	NUM
dpc-5766	54	2	;	;	PUNCT
dpc-5766	55	1	35(3):283–289	35(3):283–289	NUM
dpc-5766	55	2	.	.	PUNCT
dpc-5766	56	1	doi	doi	PROPN
dpc-5766	56	2	:	:	PUNCT
dpc-5766	56	3	10.1016	10.1016	NUM
dpc-5766	56	4	/j.det.2017.02.002	/j.det.2017.02.002	NOUN
dpc-5766	56	5	.	.	PUNCT
dpc-5766	57	1	pmid	pmid	NOUN
dpc-5766	57	2	:	:	PUNCT
dpc-5766	57	3	28577797	28577797	NUM
dpc-5766	57	4	2	2	NUM
dpc-5766	57	5	.	.	PUNCT
dpc-5766	58	1	thyssen	thyssen	PROPN
dpc-5766	58	2	jp	jp	PROPN
dpc-5766	58	3	,	,	PUNCT
dpc-5766	58	4	halling	halle	VERB
dpc-5766	58	5	a	a	DET
dpc-5766	58	6	,	,	PUNCT
dpc-5766	58	7	schmid	schmid	NOUN
dpc-5766	58	8	-	-	PUNCT
dpc-5766	58	9	grendelmeier	grendelmeier	NOUN
dpc-5766	58	10	p	p	NOUN
dpc-5766	58	11	,	,	PUNCT
dpc-5766	58	12	guttman	guttman	ADJ
dpc-5766	58	13	-	-	PUNCT
dpc-5766	58	14	yassky	yassky	NOUN
dpc-5766	58	15	e	e	NOUN
dpc-5766	58	16	,	,	PUNCT
dpc-5766	58	17	silverberg	silverberg	PROPN
dpc-5766	58	18	ji	ji	PROPN
dpc-5766	58	19	.	.	PROPN
dpc-5766	58	20	comorbidities	comorbiditie	NOUN
dpc-5766	58	21	of	of	ADP
dpc-5766	58	22	atopic	atopic	NOUN
dpc-5766	58	23	dermatitis	dermatitis	NOUN
dpc-5766	58	24	—	—	PUNCT
dpc-5766	58	25	what	what	PRON
dpc-5766	58	26	does	do	AUX
dpc-5766	58	27	the	the	DET
dpc-5766	58	28	evidence	evidence	NOUN
dpc-5766	58	29	say	say	VERB
dpc-5766	58	30	?	?	PUNCT
dpc-5766	59	1	j	j	PROPN
dpc-5766	59	2	allergy	allergy	PROPN
dpc-5766	59	3	clin	clin	PROPN
dpc-5766	59	4	immunol	immunol	PROPN
dpc-5766	59	5	.	.	PUNCT
dpc-5766	60	1	2023;151(5	2023;151(5	NUM
dpc-5766	60	2	):	):	PUNCT
dpc-5766	60	3	1155	1155	NUM
dpc-5766	60	4	-	-	SYM
dpc-5766	60	5	1162	1162	NUM
dpc-5766	60	6	.	.	PUNCT
dpc-5766	61	1	doi	doi	NOUN
dpc-5766	61	2	:	:	PUNCT
dpc-5766	61	3	10.1016	10.1016	NUM
dpc-5766	61	4	/	/	SYM
dpc-5766	61	5	j.jaci.2022.12.002	j.jaci.2022.12.002	PROPN
dpc-5766	61	6	.	.	PUNCT
dpc-5766	62	1	pmid	pmid	NOUN
dpc-5766	62	2	:	:	PUNCT
dpc-5766	62	3	36621338	36621338	NUM
dpc-5766	62	4	3	3	NUM
dpc-5766	62	5	.	.	PUNCT
dpc-5766	63	1	wollenberg	wollenberg	PROPN
dpc-5766	63	2	a	a	PROPN
dpc-5766	63	3	,	,	PUNCT
dpc-5766	63	4	kinberger	kinberger	PROPN
dpc-5766	63	5	m	m	PROPN
dpc-5766	63	6	,	,	PUNCT
dpc-5766	63	7	arents	arents	PROPN
dpc-5766	63	8	b	b	PROPN
dpc-5766	63	9	,	,	PUNCT
dpc-5766	63	10	et	et	PROPN
dpc-5766	63	11	al	al	PROPN
dpc-5766	63	12	.	.	PUNCT
dpc-5766	64	1	european	european	PROPN
dpc-5766	64	2	guideline	guideline	PROPN
dpc-5766	64	3	(	(	PUNCT
dpc-5766	64	4	euroguiderm	euroguiderm	NOUN
dpc-5766	64	5	)	)	PUNCT
dpc-5766	64	6	on	on	ADP
dpc-5766	64	7	atopic	atopic	ADJ
dpc-5766	64	8	eczema	eczema	NOUN
dpc-5766	64	9	:	:	PUNCT
dpc-5766	64	10	part	part	NOUN
dpc-5766	64	11	i	i	INTJ
dpc-5766	64	12	–	–	PUNCT
dpc-5766	64	13	systemic	systemic	ADJ
dpc-5766	64	14	therapy	therapy	NOUN
dpc-5766	64	15	.	.	PUNCT
dpc-5766	65	1	j	j	PROPN
dpc-5766	65	2	eur	eur	PROPN
dpc-5766	65	3	acad	acad	PROPN
dpc-5766	65	4	dermatol	dermatol	NOUN
dpc-5766	65	5	venereol	venereol	NOUN
dpc-5766	65	6	.	.	PUNCT
dpc-5766	66	1	2022;36(9):1409	2022;36(9):1409	NUM
dpc-5766	66	2	-	-	SYM
dpc-5766	66	3	1431	1431	NUM
dpc-5766	66	4	.	.	PUNCT
dpc-5766	67	1	doi	doi	NOUN
dpc-5766	67	2	:	:	PUNCT
dpc-5766	67	3	10.1111	10.1111	NUM
dpc-5766	67	4	/	/	SYM
dpc-5766	67	5	jdv.18345	jdv.18345	PROPN
dpc-5766	67	6	.	.	PUNCT
dpc-5766	68	1	pmid	pmid	NOUN
dpc-5766	68	2	:	:	PUNCT
dpc-5766	68	3	35980214	35980214	NUM
dpc-5766	68	4	4	4	NUM
dpc-5766	68	5	.	.	PUNCT
dpc-5766	69	1	silverberg	silverberg	PROPN
dpc-5766	69	2	,	,	PUNCT
dpc-5766	69	3	j.	j.	PROPN
dpc-5766	69	4	i.	i.	PROPN
dpc-5766	69	5	,	,	PUNCT
dpc-5766	69	6	gelfand	gelfand	PROPN
dpc-5766	69	7	,	,	PUNCT
dpc-5766	69	8	j.	j.	PROPN
dpc-5766	69	9	m.	m.	PROPN
dpc-5766	69	10	,	,	PUNCT
dpc-5766	69	11	margolis	margolis	PROPN
dpc-5766	69	12	,	,	PUNCT
dpc-5766	69	13	d.	d.	PROPN
dpc-5766	69	14	j.	j.	PROPN
dpc-5766	69	15	,	,	PUNCT
dpc-5766	69	16	et	et	PROPN
dpc-5766	69	17	al	al	PROPN
dpc-5766	69	18	.	.	PROPN
dpc-5766	69	19	association	association	PROPN
dpc-5766	69	20	of	of	ADP
dpc-5766	69	21	atopic	atopic	NOUN
dpc-5766	69	22	dermatitis	dermatitis	NOUN
dpc-5766	69	23	with	with	ADP
dpc-5766	69	24	allergic	allergic	ADJ
dpc-5766	69	25	,	,	PUNCT
dpc-5766	69	26	autoimmune	autoimmune	ADJ
dpc-5766	69	27	,	,	PUNCT
dpc-5766	69	28	and	and	CCONJ
dpc-5766	69	29	cardiovascular	cardiovascular	ADJ
dpc-5766	69	30	comorbidities	comorbiditie	NOUN
dpc-5766	69	31	in	in	ADP
dpc-5766	69	32	us	us	PROPN
dpc-5766	69	33	adults	adult	NOUN
dpc-5766	69	34	.	.	PUNCT
dpc-5766	70	1	ann	ann	PROPN
dpc-5766	70	2	allergy	allergy	PROPN
dpc-5766	70	3	asthma	asthma	PROPN
dpc-5766	70	4	immunol	immunol	PROPN
dpc-5766	70	5	2018	2018	NUM
dpc-5766	70	6	nov;121(5	nov;121(5	NUM
dpc-5766	70	7	):	):	PUNCT
dpc-5766	70	8	604612.e3	604612.e3	NOUN
dpc-5766	70	9	.	.	PUNCT
dpc-5766	71	1	doi	doi	NOUN
dpc-5766	71	2	:	:	PUNCT
dpc-5766	71	3	10.1016	10.1016	NUM
dpc-5766	71	4	/	/	SYM
dpc-5766	71	5	j.anai.2018.07.042	j.anai.2018.07.042	PROPN
dpc-5766	71	6	.	.	PUNCT
dpc-5766	72	1	pmid	pmid	NOUN
dpc-5766	72	2	:	:	PUNCT
dpc-5766	72	3	30092266	30092266	NUM
dpc-5766	72	4	5	5	NUM
dpc-5766	72	5	.	.	PUNCT
dpc-5766	72	6	mikhaylov	mikhaylov	PROPN
dpc-5766	72	7	d	d	PROPN
dpc-5766	72	8	,	,	PUNCT
dpc-5766	72	9	ungar	ungar	PROPN
dpc-5766	72	10	b	b	AUX
dpc-5766	72	11	,	,	PUNCT
dpc-5766	72	12	renert	renert	NOUN
dpc-5766	72	13	-	-	PUNCT
dpc-5766	72	14	yuval	yuval	PROPN
dpc-5766	72	15	y	y	PROPN
dpc-5766	72	16	,	,	PUNCT
dpc-5766	72	17	guttman	guttman	ADJ
dpc-5766	72	18	-	-	PUNCT
dpc-5766	72	19	yassky	yassky	NOUN
dpc-5766	72	20	e.	e.	PROPN
dpc-5766	72	21	oral	oral	PROPN
dpc-5766	72	22	janus	janus	PROPN
dpc-5766	72	23	kinase	kinase	PROPN
dpc-5766	72	24	inhibitors	inhibitor	NOUN
dpc-5766	72	25	for	for	ADP
dpc-5766	72	26	atopic	atopic	NOUN
dpc-5766	72	27	dermatitis	dermatitis	NOUN
dpc-5766	72	28	.	.	PUNCT
dpc-5766	73	1	ann	ann	PROPN
dpc-5766	73	2	allergy	allergy	PROPN
dpc-5766	73	3	asthma	asthma	PROPN
dpc-5766	73	4	immunol	immunol	PROPN
dpc-5766	73	5	.	.	PUNCT
dpc-5766	74	1	2023;130(5):577	2023;130(5):577	NUM
dpc-5766	74	2	-	-	SYM
dpc-5766	74	3	592	592	NUM
dpc-5766	74	4	.	.	PUNCT
dpc-5766	75	1	doi	doi	NOUN
dpc-5766	75	2	:	:	PUNCT
dpc-5766	75	3	10.1016	10.1016	NUM
dpc-5766	75	4	/	/	SYM
dpc-5766	75	5	j.anai	j.anai	PROPN
dpc-5766	75	6	.2023.01.031	.2023.01.031	PROPN
dpc-5766	75	7	.	.	PUNCT
dpc-5766	76	1	pmid	pmid	NOUN
dpc-5766	76	2	:	:	PUNCT
dpc-5766	76	3	37137601	37137601	NUM
dpc-5766	76	4	.	.	PUNCT
dpc-5766	77	1	6	6	NUM
dpc-5766	77	2	.	.	X
dpc-5766	77	3	simpson	simpson	PROPN
dpc-5766	77	4	,	,	PUNCT
dpc-5766	77	5	e.	e.	PROPN
dpc-5766	77	6	l.	l.	PROPN
dpc-5766	77	7	,	,	PUNCT
dpc-5766	77	8	bieber	bieber	PROPN
dpc-5766	77	9	,	,	PUNCT
dpc-5766	77	10	t.	t.	PROPN
dpc-5766	77	11	,	,	PUNCT
dpc-5766	77	12	guttman	guttman	NOUN
dpc-5766	77	13	-	-	PUNCT
dpc-5766	77	14	yassky	yassky	NOUN
dpc-5766	77	15	,	,	PUNCT
dpc-5766	77	16	e.	e.	PROPN
dpc-5766	77	17	,	,	PUNCT
dpc-5766	77	18	et	et	PROPN
dpc-5766	77	19	al	al	PROPN
dpc-5766	77	20	.	.	PROPN
dpc-5766	78	1	two	two	NUM
dpc-5766	78	2	phase	phase	NOUN
dpc-5766	78	3	3	3	NUM
dpc-5766	78	4	trials	trial	NOUN
dpc-5766	78	5	of	of	ADP
dpc-5766	78	6	dupilumab	dupilumab	NOUN
dpc-5766	78	7	versus	versus	ADP
dpc-5766	78	8	placebo	placebo	NOUN
dpc-5766	78	9	in	in	ADP
dpc-5766	78	10	atopic	atopic	NOUN
dpc-5766	78	11	dermatitis	dermatitis	NOUN
dpc-5766	78	12	.	.	PUNCT
dpc-5766	79	1	new	new	PROPN
dpc-5766	79	2	england	england	PROPN
dpc-5766	79	3	journal	journal	PROPN
dpc-5766	79	4	of	of	ADP
dpc-5766	79	5	medicine	medicine	NOUN
dpc-5766	79	6	.	.	PUNCT
dpc-5766	80	1	2016	2016	NUM
dpc-5766	80	2	dec	dec	PROPN
dpc-5766	80	3	15;375(24	15;375(24	NUM
dpc-5766	80	4	):	):	PUNCT
dpc-5766	80	5	2335	2335	NUM
dpc-5766	80	6	-	-	SYM
dpc-5766	80	7	2348	2348	NUM
dpc-5766	80	8	.	.	PUNCT
dpc-5766	81	1	doi:10.1056	doi:10.1056	PROPN
dpc-5766	81	2	/	/	SYM
dpc-5766	81	3	nejmoa1610020	nejmoa1610020	PROPN
dpc-5766	81	4	.	.	PUNCT
dpc-5766	82	1	pmid	pmid	NOUN
dpc-5766	82	2	:	:	PUNCT
dpc-5766	82	3	27690741	27690741	NUM